Rocket Lab: Why The SpaceX IPO Could Keep Fueling Its Rally

Rocket Lab is benefiting from ETF inflows and sector momentum, supported by a $2.2B backlog, 46% YoY revenue growth, and 38.2% gross margin. The stock remains expensive at 124x EV/Sales TTM, but valuation compresses to 37x by 2028 if Neutron ramps as planned. Key catalysts are Neutron's Q4 launch and a potential SpaceX IPO, while the article maintains a buy rating.

Analysis

RKLB is becoming a liquidity proxy for the entire small-sat / commercial launch theme, which means the stock can outrun fundamentals for stretches when ETF and factor flows are strong. That dynamic matters because once a name is crowded into momentum baskets, it tends to trade less on quarterly execution and more on whether the next catalyst keeps the narrative alive; in this case Neutron is the bridge between a “good niche operator” and a potential multi-year platform story. The market is likely underestimating how much of the current multiple is really an option on category expansion rather than today’s revenue base.

The second-order competitive effect is that a credible medium-lift vehicle forces customers to revisit sourcing risk across launch providers and adjacent spacecraft integrators. Even before first commercial cadence, Neutron can pressure pricing expectations for smaller competitors and may force longer-dated contracting behavior from customers who do not want to be locked into a single-provider ecosystem. If execution slips, the stock’s downside is asymmetric because the valuation already discounts a very clean ramp; any delay would collide with a crowded ownership base and could trigger a sharp factor unwind.

The key risk is timing mismatch: the catalyst path is months, but the stock is already pricing years. Near term, the trade is more about launch-day optionality and sector momentum than about backlog conversion; over the next 6-12 months, investors will pay up for evidence that growth is broadening beyond a single vehicle thesis. The contrarian read is that the market may be too focused on EV/Sales compression by 2028 and not enough on the fragility of that path if Neutron is delayed even one quarter or if gross margin expansion slows as mix shifts.

The cleanest bull case remains that RKLB is one of the few pure plays with visible catalyst density, but that also makes it vulnerable to a “good news, already priced” outcome. If the launch is successful, upside comes from multiple expansion persistence and incremental flow, not a reset higher in fundamentals overnight; if the launch disappoints, the drawdown can be severe because there is little valuation cushion. In other words, this is a momentum-plus-execution trade, not a deep value setup.

Key Decisions for Investors

• Long RKLB into Neutron-related catalysts over the next 1-3 months; use pullbacks from ETF-led squeezes as entries, but size modestly because the name is crowded and downside can be 20-30% on any launch delay.
• For event-driven upside with defined risk, buy RKLB call spreads 2-4 months out targeting the launch window; structure for 2:1 to 4:1 payout if the stock re-rates on successful milestone execution.
• Pair trade: long RKLB / short a basket of weaker small-cap space names over 6-9 months to isolate execution alpha; the spread should widen if investors reward credible launch cadence over “story-only” peers.
• If already long, trim 25-33% into launch success or sharp momentum spikes; the stock likely trades the news first and fundamentals later, so the best risk/reward often comes before the catalyst, not after.